How do animal safety studies prepare a drug for testing in humans?

Animal safety studies are conducted to evaluate the potential risks of a new medication before it is administered to humans, helping researchers select the most suitable chemical compounds and dosage forms for development. While the FDA Modernization Act 2.0 has made animal testing optional rather than a mandatory legal requirement for pharmaceutical companies, these studies remain a common component of preclinical safety assessment.12

To prepare for Phase 1 human clinical trials, researchers typically perform acute toxicity studies in two mammalian species. In these studies, a single large or potentially toxic dose is administered via the intended route of human use, and animals are monitored for one to four weeks to identify any organ or tissue toxicities.32

Beyond acute testing, safety evaluations may include:
* Subacute and chronic toxicity studies: These assess the effects of repeated drug administration over time.31
* Mutagenicity and reproductive toxicity: These tests examine the drug's potential to cause genetic damage or affect development.1
* Carcinogenicity studies: These are generally conducted for drugs intended for long-term human use (longer than six months) to determine if the substance has the potential to cause cancer.3

Ethical principles dictate that animal welfare must be prioritized; researchers are encouraged to follow the "three Rs" (replacement, reduction, and refinement) to minimize pain and distress.4